The Dixie Group Reports First Quarter 2018 Results
May 03, 2018 08:00 am UTC| Business
DALTON, Ga., May 03, 2018 -- The Dixie Group, Inc. (NASDAQ:DXYN) today reported financial results for the quarter ended March 31, 2018. For the first quarter of 2018, the Company had net sales of $98,858,000 as compared...
American Pacific Mining Vends Out JPL Property to AAA Equity Holdings
May 03, 2018 08:00 am UTC| Business
VANCOUVER, British Columbia, May 03, 2018 -- American Pacific Mining Corp (CSE:USGD) (FWB:1QC) (OTCPK:USGDF) (“APM” or the “Company”) is pleased to announce that the Company, through its wholly-owned subsidiary,...
Organ-on-Chip Market to reach $163.1 Million by 2025: P&S Market Research
May 03, 2018 07:38 am UTC| Business
NEW YORK, May 03, 2018 -- According to the market research report published by PS Market Research, global organ-on-chip market size is forecasted to reach $163.1 million by 2025, the growth in the market will be led by...
Cameo Resources Corp. to Undergo 3 for 1 Forward Share Split and Name Change
May 03, 2018 07:05 am UTC| Business
VANCOUVER, British Columbia, May 03, 2018 -- Cameo Resources Corp. (TSX Venture:CRU) (OTC:CRUUF) (FWB:SY7D) (the “Company” or “Cameo Resources”) is pleased to announce the Company’s common shares will be split on the...
Esperanto Technologies Engineers to Present at RISC-V Workshop Barcelona
May 03, 2018 07:01 am UTC| Business
MOUNTAIN VIEW, Calif., May 03, 2018 -- Esperanto Technologies™, a developer of high-performance, energy-efficient computing solutions based on RISC-V for artificial intelligence and machine learning applications, will...
St. John's University harnesses ADVA FSP 3000 for 100G R&E network
May 03, 2018 07:00 am UTC| Business
ADVA and Techgardens partner to deliver highly efficient, fully redundant core transport solution New York, New York, USA. May 3, 2018. ADVA (FSE: ADV) today announced that St. John's University has deployed its...
May 03, 2018 07:00 am UTC| Business
BOSTON and LONDON, May 03, 2018 -- Orchard Therapeutics, a leading commercial stage company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, today announced that the...